can't read?
Orlistat, used in obesity research, is a pancreatic lipase inhibitor that acts locally in the gastrointestinal tract to inhibit lipase.
O 0392 (OTTO) Orlistat, ≥98% Cas 96829-58-2 - used as an inhibitor of fatty acid synthase in long-term estrogen-deprived (LTED) variant cell lines.